ABSTRACT. Antimicrobial susceptibility of 183 Salmonella isolates from apparently healthy food-producing animals obtained during the period from 2000 to 2003 throughout Japan was examined. Of 29 serovars identified, Salmonella Infantis (37.7%) was the most prevalent, followed by S. Typhimurium (19.7%). Salmonella bacteria resistant to dihydrostreptomycin (77.6%) were about 10% more prevalent than those resistant to oxytetracycline (67.8%), though the nation-level veterinary use of tetracycline antibiotics is much greater than that of streptomycin in Japan. In seventeen isolates (9.3%) resistant to nalidixic acid, single point mutations were detected at 84 or 87 in the quinolone resistance-determining region of the gyrA gene.
Salmonella, recognized as a causative agent of foodborne diseases, may cause gastrointestinal disease in humans and animals. It is sometimes present in the intestinal tract in food-producing animals. The use of antimicrobial agents in humans and animals can lead to the emergence of antimicrobial-resistant bacteria [1, 17] . In Japan, the occurrence of antimicrobial resistance in bacteria in food-producing animals has been monitored in the Japanese Veterinary Antimicrobial Resistance Monitoring (JVARM) system since 1999 [16] . Since the first stage of the JVARM program was completed in 2003, we show here data on the antimicrobial susceptibility of Salmonella isolates obtained from cattle, pigs, and broiler and layer chickens throughout Japan from 2000 to 2003.
In the JVARM program, the 47 prefectures of Japan were divided into four groups selected evenly on the basis of geographical difference from northern to southern areas (11 or 12 prefectures per year). Sampling and bacterial isolation were carried out at livestock hygiene service centers. In brief, freshly voided fecal samples were taken from healthy beef cattle, pigs and broiler and layer chickens at the farm. In most cases, six samples per animal species were collected from different farms in each prefecture. One gram of fecal sample was inoculated into 10 ml of Hajna tetrathionate broth, followed by incubation at 42°C for 18 hr or an additional 5-7 days at room temperature as delayed secondary enrichment culture. After incubation, each culture was streaked onto DHL and brilliant green agar plates each containing 20 µg/ml of novobiocin. Candidate colonies were identified biochemically. Identification of isolates for serovar was then performed by slide and tube agglutination according to the latest versions of the Kauffmann-White scheme.
Salmonella [2] , 104 isolates were subjected to antimicrobial susceptibility testing. The MICs of each antimicrobial were interpreted using the NCCLS criteria [12] . The resistant breakpoints of dihydrostreptomycin (DSM), oxytetracycline (OTC), bicozamycin (BCM), colistin (CL), oxalic acid (OA), enrofloxacin (ERFX) and ofloxacin (OFLX) were determined according to our previous report [6] .
Resistance was found for 9 of 20 antimicrobials tested, 77.6% for DSM and 67.8% for OTC (Table 2) . Salmonella resistant to DSM was about 10% more prevalent than that resistant to OTC, though the nation-level veterinary use of tetracycline antibiotics is much greater than that of streptomycin [17] . In Japan, the frequency of OTC resistance was higher than that of DSM resistance in Escherichia coli isolates from apparently healthy food-producing animals [9] . The antimicrobial resistance rates of E. coli isolates were significantly correlated to the usage of antimicrobial agents in food-producing animals [3] . However, the overall usage of veterinary antimicrobials did not necessarily contribute to appearance of antimicrobial resistance in Salmonella isolates. Someya et al. [16] have shown the persistence of antimicrobial-resistant Salmonella in layer chicken flocks without antimicrobial selective pressure.
There were no significant differences in resistance rates to the antimicrobials tested except for ABPC among the 4 years. The resistance rate to ABPC decreased from 29.7% in 2000 to 0% in 2003 (Table 2 ). However, no isolates originating from cattle were obtained in 2003, in which resistance to ABPC was frequently found. A small number of isolates were used for antimicrobial susceptibility tests in 2001 and 2003. Thus, it is difficult to appraise the annual data of antimicrobial resistance in Salmonella isolates from food-producing animals in JVARM program.
The present study showed that 131 (71.6%) isolates were resistant to two or more of the antimicrobials tested ( [2] . b) Data from our previous report [6] were interrupted according to resistant breakpoint in this study. dissemination of S. Typhimurium in cattle/pigs and S. Infantis in poultry [6] . In our previous study carried out between 1999 and 2001, DT104 was found in 53.1% of S. Typhimurium isolates from food-producing animals [5] . In Japan, S. Typhimurium DT104 was first isolated in the late 1980s and has spread widely among domestic animals in Japan in the past decade [15] . S. Infantis from retail broiler meats increased in 1997 [10] , and the isolates from broiler meats harbored antimicrobial-resistant types similar to those of broiler isolates [2] . The prevalence of MAR S. Infantis is much higher in broilers in Japan than in other countries [8, 14] . Both serovars have been prevalent on farms in Japan for a long time. Therefore, eradication of Salmonella from herds is essential for resolving the problem of antimicrobial resistance as well as for maintenance of public and animal health.
Fluoroquinolones have been used for veterinary medicine in Japan since approval in 1991, and the use of fluoroquinolones has been increasing since around 1992 [18] . Fluoroquinolone resistance in E. coli has increased in foodproducing animals in Japan [9] . All of the isolates were susceptible to fluoroquinolones (ERFX and OFLX), though 17 isolates exhibited resistance to quinolones (nalidixic acid (NA) and OA). Resistance to quinolones in Salmonella can be caused by alterations in the target enzymes (DNA gyrase and topoisomerase IV), decreased permeability of drugs, or an active efflux mechanism [13] . Point mutations in the quinolone resistance-determining region (QRDR) of the gyrA gene in the GyrA subunit of DNA gyrase have frequently been detected in Salmonella [7, 13] . Mutations in the QRDRs of the gyrA, gyrB and parC genes were detected by direct DNA sequencing. Amplification of the genes and purification of amplicons were performed as described previously [7] . Nucleotide sequence was determined by using a Dye Terminator Cycle Sequencing Ready Kit with a 310 genetic analyzer (Applied Biosystems). In all of the quinolone-resistant isolates, single point mutations in the QRDR were detected in the gyrA gene but not in the gyrB and parC genes (Table 4) . Recently, we reported that fluoroquinolone-resistant S. Choleraesuis from a diseased pig in 2001 had two point mutations in the gyrA gene and a mutation in the parC gene [4] . Levels of resistance of Salmonella to quinolones were markedly higher in broiler isolates. The rate of resistance of E. coli to ERFX increased in broiler iso- lates from 0% in 1992 to 9.9% in 1999 [9] and to 3.1% in 2001 [3] . Fluoroquinolones are one of the most valuable antimicrobial classes available for treating human infection. We will continue to monitor fluoroquinolone resistance and its use in food-producing animals in order to prevent the spread of fluoroquinolone-resistant Salmonella.
In the 1st stage of JVARM, antimicrobial susceptibility of Salmonella isolates to 20 antimicrobials was examined. MIC of cefuroxime was found to be similar to that of cefazolin even though the generation levels of cephalosporin are different. Both destomycin A and olaquindox were ingredients of antimicrobial growth promoter for gram-positive bacteria, and MIC distributions of them were not bimodal. Developments of resistance to OA and OFLX were similar to those of NA and ERFX, respectively. In prior consultation for the 2nd stage, the following antimicrobials were excluded from the targeted agents on the basis of the results obtained in the1st stage of JVARM: cefuroxime, destomycin A, OA, OFLX, and olaquindox. a) Data of mutation in the gyrA gene from our previous study [2] .
